Deep‐targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma

Documenti analoghi

• The unfolded protein response machinery in glioblastoma genesis, chemoresistance and as a druggable target
  di: Lucette Z. Simbilyabo, et al.
  Pubblicazione: (2024)
• Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma
  di: Guangcai Shao, et al.
  Pubblicazione: (2024)
• Theory and application of TTFields in newly diagnosed glioblastoma
  di: Ao Yu, et al.
  Pubblicazione: (2024)
• Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells‐derived exosomes
  di: Xinglei Liu, et al.
  Pubblicazione: (2024)
• Identification of TMZ resistance‐associated histone post‐translational modifications in glioblastoma using multi‐omics data
  di: Liguo Ye, et al.
  Pubblicazione: (2024)